Article Name Clinical & Diagnostic
Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to optimize laboratory workflows and support critical clinical decisions.
26th July, 2023
Fractus' groundbreaking antenna technology now ventures into the realm of healthcare. The company has successfully developed an innovative wireless implantable device technology, revolutionizing the way doctors remotely monitor their patients and boosting the uptake of telehealth services by leveraging wireless connectivity. With the ability to offer real-time data and feedback, this cutting-edge technology is set to greatly improve patient care, enabling doctors to make timely, informed decisions and fostering personalized consultations that actively engage patients in their treatment journeys.
25th July, 2023
Apollo leads India's Solid Multi-Organ Transplantation with over 23000 transplants, establishes global leadership
25th July, 2023
Novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
25th July, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the updated BD Alaris™ Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the United States.
24th July, 2023
Association mission remains the same—better health through laboratory medicine.
24th July, 2023
Initial clinical study results will inform pivotal clinical trial in U.S. and Europe
21st July, 2023
Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their expanded partnership where DOHC will offer Lark's Prevention program and CDC-recognized Diabetes Prevention program to their patients.
21st July, 2023
Technology enables inference of subjective outcomes from routinely collected data
20th July, 2023
Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea.
20th July, 2023
Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery
19th July, 2023
Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter’s High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay Analyzers
18th July, 2023
Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements.
18th July, 2023
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments.
18th July, 2023
UK-based The Rodnight Partnership ties up with India's Pluss
18th July, 2023
Patient-Led Global Summit on Science, Policy, and Care Choice Drives Optimism
17th July, 2023
Affirms Strong Performance and Focus on India Amidst Ongoing Expansion
17th July, 2023
Brings Delhi’s first-ever comprehensive preventive health solution called Smart Gene Plan
17th July, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer